Discovery through Machine Learning and Preclinical Validation of Novel Anti-Diabetic Peptides

While there have been significant advances in drug discovery for diabetes mellitus over the past couple of decades, there is an opportunity and need for improved therapies. While type 2 diabetic patients better manage their illness, many of the therapeutics in this area are peptide hormones with len...

Descripción completa

Detalles Bibliográficos
Autores principales: Casey, Rory, Adelfio, Alessandro, Connolly, Martin, Wall, Audrey, Holyer, Ian, Khaldi, Nora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000967/
https://www.ncbi.nlm.nih.gov/pubmed/33803471
http://dx.doi.org/10.3390/biomedicines9030276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000967/
https://www.ncbi.nlm.nih.gov/pubmed/33803471
http://dx.doi.org/10.3390/biomedicines9030276

Ejemplares similares